Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3 USD | +5.26% | +5.26% | +15.38% |
2022 | PharmChem, Inc.'s Equity Buyback announced on May 2, 2022, has cancelled. | CI |
2022 | PharmChem, Inc. announces an Equity Buyback for $5 million worth of its shares. | CI |
Sales 2001 | 43.98M 59.92M | Sales 2002 | 30.08M 40.99M | Capitalization | 1.35M 1.83M |
---|---|---|---|---|---|
Net income 2001 | -8M -10.9M | Net income 2002 | 3M 4.09M | EV / Sales 2001 | 0.37 x |
Net Debt 2001 | 10.89M 14.84M | Net Debt 2002 | 2.32M 3.17M | EV / Sales 2002 | 0.12 x |
P/E ratio 2001 |
-0.66
x | P/E ratio 2002 |
0.4
x | Employees | - |
Yield 2001 * |
-
| Yield 2002 |
-
| Free-Float | 96.52% |
1 day | +5.26% | ||
1 week | +5.26% | ||
1 month | +9.09% | ||
3 months | +11.52% | ||
6 months | +17.65% | ||
Current year | +15.38% |
Managers | Title | Age | Since |
---|---|---|---|
Thompson Clark
CEO | Chief Executive Officer | - | - |
Shana Veale
DFI | Director of Finance/CFO | - | 17-08-31 |
Douglas Crook
COO | Chief Operating Officer | - | 96-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Thompson Clark
CEO | Chief Executive Officer | - | - |
Tim Eriksen
CHM | Chairman | 55 | 21-08-30 |
James Ford
BRD | Director/Board Member | - | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-30 | 3 | +5.26% | 788 |
24-05-24 | 2.85 | +1.79% | 500 |
Delayed Quote OTC Markets, May 30, 2024 at 03:02 pm
More quotes1st Jan change | Capi. | |
---|---|---|
+15.38% | 13.94M | |
-24.16% | 7.76B | |
+68.65% | 4.33B | |
+2.72% | 2.63B | |
-2.98% | 2.64B | |
-46.17% | 2.16B | |
-15.27% | 1.75B | |
-22.12% | 1.46B | |
+13.62% | 1.17B | |
-43.81% | 1.14B |
- Stock Market
- Equities
- PCHM Stock